Immunic, Inc. (IMUX)
6.93
-1.02
(-12.83%)
USD |
NASDAQ |
Oct 13, 16:00
6.99
+0.06
(+0.87%)
After-Hours: 20:00
Immunic Net Income (Annual) : -97.17M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -97.17M |
| December 31, 2024 | -100.51M |
| December 31, 2023 | -93.61M |
| December 31, 2022 | -120.41M |
| December 31, 2021 | -92.94M |
| December 31, 2020 | -44.02M |
| December 31, 2019 | -34.93M |
| December 31, 2018 | -11.54M |
| Date | Value |
|---|---|
| December 31, 2017 | -52.08M |
| December 31, 2016 | -40.97M |
| December 31, 2015 | -52.02M |
| December 31, 2014 | -47.67M |
| December 31, 2013 | -31.41M |
| December 31, 2012 | -9.62M |
| December 31, 2011 | -6.417M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Sionna Therapeutics, Inc. | -75.27M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Anika Therapeutics, Inc. | -9.979M |
| Savara, Inc. | -118.84M |